Clinical trial
Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients
NCT04638712 is registered in ClinicalTrials.gov with Institut de cancérologie Strasbourg Europe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients
- Lead sponsor
- Institut de cancérologie Strasbourg Europe
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 16, 2020
- Completion date
- May 20, 2021
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer